# The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

> **NCT00467896** · PHASE2 · TERMINATED · sponsor: **Actelion** · enrollment: 62 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Iloprost PD-6
- **DRUG:** Iloprost PD-15

## Key facts

- **NCT ID:** NCT00467896
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2010-11
- **Final completion:** 2011-06
- **Target enrollment:** 62 (ACTUAL)
- **Why stopped:** Sponsor's decision
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467896, "The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00467896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*